test_moissonnage_selune
type: Agent

Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
type: Dataset
contact point: Organization
  fn: CCSD
keyword: mesh-pentetic-acid
keyword: mesh-neoplasm-metastasis
keyword: mesh-animals
keyword: mesh-thyroid-neoplasms
keyword: mesh-humans
keyword: mesh-middle-aged
keyword: mesh-male
keyword: mesh-treatment-outcome
keyword: infoeu-reposemanticsarticle
keyword: mesh-young-adult
keyword: mesh-aged-80-and-over
keyword: mesh-aged
keyword: mesh-tumor-markers-biological
keyword: mesh-mice
keyword: mesh-disease-progression
keyword: mesh-carcinoembryonic-antigen
keyword: journal-articles
keyword: mesh-adult
keyword: mesh-antibodies-bispecific
keyword: sdvlife-sciences-q-bio
keyword: mesh-radioimmunotherapy
keyword: mesh-antibodies-monoclonal-humanized
keyword: mesh-survival-analysis
landing page: 0161-5505
description: International audience
issued: 2026-05-07T09:19:51.037784
language: en
modified: 2026-05-07T09:19:51.037789

Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
type: Distribution
access URL: https://hal.univ-brest.fr/hal-00932253
format: HTML
issued: 2026-05-07T09:19:51.040604
modified: 2026-05-07T09:19:51.015852